FDA issued a Warning Letter to Vista Pharmaceuticals Limited on 7/5/2017 as a result of this inspection.
FDA investigators audited the Vista Pharmaceuticals - Nalgonda District, India facility and issued inspectional observations (via FDA 483) on 23 Sep 2016.
Add To Cart
- Category: Human Drugs
- Inspection end: 23 Sep 2016
- Location: Nalgonda District, India
- FEI: 3003978209